Marion Odence Ford Optimize Rx Corp (OPRX) insider trading activity

Marion Odence Ford is General Counsel and CCO of OptimizeRx Corp. Currently has a direct ownership of 27,230 shares of OPRX, which is worth approximately $133,699. The most recent transaction as insider was on Dec 20, 2024, when has been sold 1,153 shares (Common Stock) at a price of $4.75 per share, resulting in proceeds of $5,476. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 27.2K

91.34% 3M change

80.16% 12M change

Total Value Held $133,699

Marion Odence-Ford Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 20 2024	SELL Payment of exercise price or tax liability	$5,476 $4.75 p/Share	1,153 Reduced 4.06%	27,230 Common Stock
Dec 19 2024	BUY Exercise of conversion of derivative security	-	3,927 Added 12.15%	28,383 Common Stock
Nov 08 2024	SELL Payment of exercise price or tax liability	$3,285 $6.27 p/Share	524 Reduced 2.1%	24,456 Common Stock
Nov 08 2024	BUY Exercise of conversion of derivative security	-	1,785 Added 6.67%	24,980 Common Stock
Oct 03 2024	SELL Payment of exercise price or tax liability	$15,284 $7.83 p/Share	1,952 Reduced 7.76%	23,195 Common Stock
Oct 03 2024	BUY Exercise of conversion of derivative security	-	6,649 Added 20.91%	25,147 Common Stock
Mar 01 2024	SELL Payment of exercise price or tax liability	$4,274 $15.95 p/Share	268 Reduced 1.85%	14,231 Common Stock
Mar 01 2024	BUY Exercise of conversion of derivative security	-	771 Added 5.05%	14,499 Common Stock
Feb 15 2024	BUY Grant, award, or other acquisition	-	4,267 Added 18.74%	18,498 Common Stock
Feb 11 2024	SELL Payment of exercise price or tax liability	$21,330 $15.39 p/Share	1,386 Reduced 9.17%	13,728 Common Stock
Feb 11 2024	BUY Exercise of conversion of derivative security	-	4,000 Added 20.93%	15,114 Common Stock
Jan 09 2024	SELL Open market or private sale	$60,760 $15.19 p/Share	4,000 Reduced 26.47%	11,114 Common Stock
Nov 08 2023	SELL Payment of exercise price or tax liability	$4,826 $9.21 p/Share	524 Reduced 3.35%	15,114 Common Stock
Nov 08 2023	BUY Exercise of conversion of derivative security	-	1,785 Added 10.25%	15,638 Common Stock
Oct 03 2023	SELL Payment of exercise price or tax liability	$13,781 $7.06 p/Share	1,952 Reduced 12.35%	13,853 Common Stock
Oct 03 2023	BUY Exercise of conversion of derivative security	-	6,649 Added 29.61%	15,805 Common Stock
Mar 01 2023	SELL Payment of exercise price or tax liability	$4,853 $18.11 p/Share	268 Reduced 2.84%	9,156 Common Stock
Mar 01 2023	BUY Exercise of conversion of derivative security	-	771 Added 7.56%	9,424 Common Stock
Feb 11 2023	SELL Payment of exercise price or tax liability	$24,657 $17.34 p/Share	1,422 Reduced 14.11%	8,653 Common Stock
Feb 11 2023	BUY Exercise of conversion of derivative security	-	4,000 Added 28.42%	10,075 Common Stock
Nov 08 2022	SELL Payment of exercise price or tax liability	$10,309 $14.52 p/Share	710 Reduced 10.46%	6,075 Common Stock
Nov 08 2022	BUY Exercise of conversion of derivative security	-	1,785 Added 20.83%	6,785 Common Stock
Aug 26 2022	BUY Open market or private purchase	$15,750 $15.75 p/Share	1,000 Added 16.67%	5,000 Common Stock
Feb 11 2022	BUY Exercise of conversion of derivative security	-	4,000 Added 50.0%	4,000 Common Stock

Marion Odence Ford

General Counsel and CCO

Rochester, MI

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OPRX shares.

Notify only if

Value

Insider Trading

Get notified when an Optimize Rx Corp insider buys or sells OPRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to OptimizeRx Corp

Track Activities on OPRX

Account